NYSE:CVS - CVS Health Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $62.66 -1.56 (-2.43 %) (As of 02/21/2019 12:32 PM ET)Previous Close$64.22Today's Range$62.52 - $64.5052-Week Range$60.14 - $82.15Volume594,791 shsAverage Volume8.39 million shsMarket Capitalization$63.84 billionP/E Ratio10.62Dividend Yield2.86%Beta1.03 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings CVS Health (NYSE:CVS) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.17 Wall Street analysts have issued ratings and price targets for CVS Health in the last 12 months. Their average twelve-month price target is $87.25, suggesting that the stock has a possible upside of 39.24%. The high price target for CVS is $100.00 and the low price target for CVS is $68.00. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.822.822.882.88Ratings Breakdown: 0 Sell Rating(s)3 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)3 Hold Rating(s)14 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)11 Buy Rating(s)2 Strong Buy Rating(s)0 Sell Rating(s)4 Hold Rating(s)11 Buy Rating(s)2 Strong Buy Rating(s)Consensus Price Target: $87.25$91.4375$90.9333$86.6667Price Target Upside: 39.24% upside43.05% upside12.43% upside27.13% upsideCVS Health (NYSE:CVS) Consensus Price Target History CVS Health (NYSE:CVS) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/21/2019SunTrust BanksLower Price TargetBuy$85.00Low2/21/2019UBS GroupLower Price TargetBuy ➝ Buy$75.00 ➝ $74.00High2/21/2019Loop CapitalLower Price TargetIn-Line ➝ Hold$68.00High2/21/2019JPMorgan Chase & Co.Reiterated RatingOverweight$91.00High2/21/2019Cantor FitzgeraldReiterated RatingOverweight$80.00Medium2/20/2019Wells Fargo & CoDowngradeOutperform ➝ Market Perform$104.00 ➝ $68.00High1/3/2019Bank of AmericaReiterated RatingBuy$92.00Low12/18/2018BarclaysInitiated CoverageOverweight ➝ Overweight$91.00Medium12/11/2018Leerink SwannInitiated CoverageOutperformMedium11/29/2018Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$87.00Low11/28/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$89.00Low11/13/2018ArgusBoost Price TargetBuy$100.00Low11/7/2018Morgan StanleySet Price TargetBuy$80.00 ➝ $100.00Low11/7/2018Royal Bank of CanadaSet Price TargetBuy$100.00Medium10/26/2018Tigress FinancialReiterated RatingBuyLow10/25/2018Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow7/9/2018CitigroupReiterated RatingNeutral ➝ Buy$81.00Low6/30/2018MizuhoReiterated RatingBuyLow2/9/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$85.00 ➝ $80.00Low2/9/2018Needham & Company LLCSet Price TargetStrong-Buy ➝ Buy$100.00 ➝ $98.00Medium1/18/2018CowenReiterated RatingOutperform$81.00 ➝ $99.00Low1/4/2018Raymond JamesUpgradeOutperform ➝ Strong-Buy$90.00High12/5/2017Deutsche BankReiterated RatingBuy ➝ HoldMedium12/4/2017Jefferies Financial GroupSet Price TargetHold$76.00Medium10/9/2017OppenheimerReiterated RatingBuy$95.00N/A7/3/2017GuggenheimReiterated RatingBuyLow(Data available from 2/21/2017 forward) This page was last updated on 2/21/2019 by MarketBeat.com StaffFeatured Article: What is an SEC Filing?